Related Experiment Video
Updated: Jun 16, 2026
Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
Published on: July 22, 2020
Unveiling VARS1: a key driver of colorectal cancer progression and immune modulation
Jiale Mei1,2, Yuman Wu2, Sicheng Zhao2
1Colorectal and Anal Disease Unit, Department of Gastrointestinal Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, People's Republic of China.
Background:
Colorectal cancer (CRC) is a leading cause of cancer-related mortality worldwide. Valyl-tRNA synthetase 1 (VARS1), an aminoacyl-tRNA synthetase, has been implicated in various cancers, but its role in CRC remains unclear. This study investigated the expression pattern, clinical significance, biological functions, and potential molecular associations of VARS1 in CRC.
Methods:
VARS1 expression was analyzed in CRC tissues using TCGA/GEO databases, immunohistochemistry, and Western blotting. Prognostic models were built via Cox regression and nomograms. In vitro, VARS1 was knocked down in CRC cell lines to assess proliferation (CCK-8, colony formation), migration/invasion (wound healing, Transwell), and EMT markers. Immune infiltration was evaluated with TIMER/CIBERSORT, single-cell analysis via Seurat/CellChat, drug sensitivity via GDSC2, and pathways via GO/KEGG/GSEA.
Results:
VARS1 was overexpressed in CRC, correlating with poor survival as an independent risk factor. Knockdown suppressed cell proliferation, migration, invasion, accompanied by changes in EMT-related markers. High VARS1 expression was associated with reduced CD8+ T-cell infiltration and altered predicted cell-cell communication patterns within the tumor microenvironment. VARS1 was associated with altered predicted chemotherapy sensitivity. GSEA and phosphorylation analyses suggested a potential association between VARS1 and JAK/STAT pathway activity.
Conclusion:
Our findings suggest that VARS1 is associated with malignant phenotypes, immune-related features, and chemotherapy response in CRC, and may serve as a potential prognostic biomarker.
Related Concept Videos
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
02:40Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...